cas 536721-25-2|| where to buy N-(1-oxohexadecyl)-L-glutamic acid tert-butyl ester

Nom du produit:N-(1-oxohexadecyl)-L-glutamic acid tert-butyl ester

IUPAC Name:(4S)-5-(tert-butoxy)-4-hexadecanamido-5-oxopentanoic acid

Unité d'emballage	Stock disponible	Prix($)	Quantité
CM336228-10g	1-2 Weeks	ǯƻň

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 536721-25-2 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:536721-25-2; Formule moléculaire:C25H47NO5; Point de fusion:-; Code SMILES:O=C(O)CC[C@@H](C(OC(C)(C)C)=O)NC(CCCCCCCCCCCCCCC)=O; Densité:

: Numéro de catalogue:CM336228; Poids moléculaire:441.65; Point d'ébullition:; N° Mdl:; Stockage:

: Fatty Acid Modified Side Chains; Fatty acid-modified side chains are small molecule modifiers and are one of the important factors that change the pharmacokinetic behavior of insulin products. Peptide drugs have the problem of short half-life and easy degradation in clinical practice. Introducing fatty acid-modified side chains into peptide drugs can increase the hydrophobicity of the drug and increase the biological half-life, thereby reducing the dosage and frequency of medication.